LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Manufacturing Facility
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • Quality System
      • CDMO Service
      • Quality Control
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries
  • Stock Info
  • Disclosure
  • Financial Information
  • IR Inquiries

Disclosure

2023-03-29 00:16:14
No.DateDisclosure Contents
102023.03.27Other Management Information(Voluntary Disclosure)(전환우선주 전환가액 조정)
92023.03.23Outcomes of Annual Meeting of Shareholders
82023.03.15Decision on Paid-in Capital Increase(Material Management Matters of Subsidiary Company)
72023.03.15Decision on Acquisition of Shares or Investment Securities of Other Corporation
62023.03.15Submission of Audit Report
52023.02.20[Revised]30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
42023.02.0630% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
32023.02.06Resolutions for Convocation of General Meeting of Shareholders
22022.12.26Other Management Information(Voluntary Disclosure)(전환우선주 전환가액 조정)
12022.11.04Interim Report on Business Performance(Fair Disclosure)
  • Stock Info
  • Disclosure
  • Financial Information
  • IR Inquiries

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

CS CENTER
ONLINE INQUIRY

Latest News

·
MEDIPOST Enhances its Partnership with Canada’s OmniaBio in Collaboration for the CMDO Business of OmniaBio’s All-Around Cell and Gene Therapy.2022.12.01
·
Medipost to launch a CDMO business for cell and gene therapy products in Korea based on 20 years of research and production knowledge2022.10.17
·
Canada’s OmniaBio, MEDIPOST affiliate begins CDMO cGMP for cell gene therapy2022.10.07
·
MEDIPOST’s 5-year follow-up of phase 3 clinical trial patients receives 2021 OJSM award2022.07.18
·
Medipost enters North American market by acquiring OmniaBio, a CDMO company with cell and gene therapy products2022.05.31

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST